New analysis projects VOQUEZNA® (vonoprazan) to provide meaningful economic value and be cost-effective vs. proton pump inhibitors (PPIs) for ...

HEALDSBURG, CA / ACCESS Newswire / October 12, 2026 / ISOThrive Inc. today announced final results from its Phase 2 trial of MHS-1031 in patients with non-erosive reflux disease (NERD) who experience ...

Dave has now been given a prognosis of six to 12 months. His wife Samantha is desperately trying to raise £60,000 to help ...

Even the doctors said there was probably nothing wrong and prescribed medicine for acid reflux ...

Dr. Oz tackles GMO labeling, consumer rights, and the "Dark Act." Plus, the science of picky eating, a breast cancer survivor ...

Adding protein to your evening meal could help prevent early-morning wake-ups that some people mistakenly blame on their ...

Detailed analysis from the randomized, double-blind, placebo-controlled Phase 3 TRIUMpH-NERD study demonstrated that both ...

VOQUEZNA (vonoprazan) is a potassium-competitive acid blocker (PCAB) that reduces stomach acid production. It is approved in the U.S. for adults with erosive GERD, heartburn associated with ...

I suspect that omeprazole is the key here. This is a type of proton-pump inhibitor - drugs widely prescribed to treat reflux.

Living with reflux, frequent heartburn, or a hernia doesn't have to be your normal. Riverwood Healthcare Center invites ...

The product is marketed as helping babies with "better sleep." ...